Stay updated on BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.

Latest updates to the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedA new 'Revision: v3.3.3' entry is added and the 'HHS Vulnerability Disclosure' link as well as the 'Revision: v3.3.2' entry are removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedOnly the site revision label in the footer changed from v3.2.0 to v3.3.2; no study-data or page content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding and operating status notice from the page header. The notice previously stated that information may not be up to date due to funding lapses and directed users to other sites for status updates.SummaryDifference0.4%

- Check54 days agoChange DetectedLatest version (2025-10-14) adds IPDSharing information to the study record, updating the Oversight section to reflect data-sharing status.SummaryDifference0.1%

- Check68 days agoChange DetectedAdds new dated study status and contact/location sections for October 2025 and removes an August 2025 entry, updating time-sensitive content.SummaryDifference2%

- Check83 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference9%

Stay in the know with updates to BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.